Back to mobile site

UBS Downgrades Chemours (CC) to Neutral, 'Waiting for the dust to settle'

March 4, 2024 10:41 PM EST Send to a Friend
(Updated - March 5, 2024 4:24 AM EST)

UBS analyst Joshua Spector downgraded Chemours (NYSE: CC) from Buy to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login